FDA signs off on COVID booster shots for seniors and high-risk people

FDA signs off on COVID booster shots for seniors and high-risk people

UNDATED (AP) — The U.S. has moved a step closer to offering booster doses of Pfizer’s COVID-19 vaccine to senior citizens and others at high risk from the virus.

The Food and Drug Administration signed off yesterday on the targeted use of extra shots.

The FDA authorized booster doses for Americans 65 and older. Also cleared to get the boosters: younger adults with underlying health conditions and those in jobs that put them at high risk for COVID-19.

The ruling represents a drastically scaled back version of the Biden administration’s sweeping plan to give third doses to nearly all American adults to shore up their protection amid the spread of the highly contagious delta variant.

However, more regulatory hurdles lie ahead before the dispensing of boosters can begin.

Photo: A nurse inoculates Sarah Luisi, of Uniondale, N.Y., with the Johnson & Johnson’s one-dose COVID-19 vaccine at the Vaxmobile, at the Uniondale Hempstead Senior Center, Wednesday, March 31, 2021, in Uniondale, N.Y. (AP Photo/Mary Altaffer)